The Biden administration plans to allocate only specific amounts of COVID-19 antibody treatments to each state amid soaring demand from GOP governors who have been focusing on the drug as a pivotal medication to fight the virus.
According to Politico, the federal health officials, in a new approach, intend to evenly distribute the 150,000 doses that the government makes available each week.
The measure comes as more and more Republican governors have been tapping the antibody treatments as a primary weapon against the CCP (Chinese Communist Party) virus or COVID-19.
Until recently, the Biden administration shipped the antibody treatments to states on an as-needed basis, with health officials even encouraging those states battling the Delta variant to seek more supply.
But demand from some states has exploded since then, with seven states—Texas, Florida, Mississippi, Tennessee, Georgia, Louisiana, and Alabama—accounting for 70% of all orders in early September.
Concerned about their consumption of a disproportionate amount of the national supply, the administration had to seek measures to control supply.
But the approach is likely to heighten tensions between the Biden administration and GOP governors whose states have been making antibody drugs the central part of their pandemic strategy.
The Biden administration has opted to boost their vaccine agenda to battle the pandemic, announcing a vaccine mandate for businesses of more than 100 employees earlier this month.
In a speech last week, Biden vowed that if “governors won’t help us beat the pandemic, I’ll use my power as president to get them out of the way.”
In late July, the Food and Drug Administration approved COVID antibody treatment as a preventive after exposure.